These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2484330)

  • 1. New anticancer agents.
    Weiss GR; Arteaga CL; Brown TD; Craig JB; Harman GS; Koeller JM; Kuhn JG; Von Hoff DD
    Cancer Chemother Biol Response Modif; 1987; 9():93-120. PubMed ID: 2484330
    [No Abstract]   [Full Text] [Related]  

  • 2. New anticancer agents.
    Brown TD; Burris HA; Havlin KA; O'Rourke TJ; Rodriguez GI; Wall JG; Weiss GR
    Cancer Chemother Biol Response Modif; 1991; 12():111-46. PubMed ID: 1718374
    [No Abstract]   [Full Text] [Related]  

  • 3. New anticancer agents.
    Weiss GR; Arteaga CL; Brown TD; Craig JB; Harman GS; Havlin KA; Koeller JM; Kuhn JG; Von Hoff DD
    Cancer Chemother Biol Response Modif; 1988; 10():85-116. PubMed ID: 2484323
    [No Abstract]   [Full Text] [Related]  

  • 4. New chemotherapeutic agents for non-Hodgkin's lymphomas.
    Cheson BD
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):1027-51. PubMed ID: 1718938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-resistance to purine analogs in hairy cell leukemia.
    Kraut EH
    Ann Intern Med; 1994 Feb; 120(3):247-8. PubMed ID: 7506014
    [No Abstract]   [Full Text] [Related]  

  • 6. Purine nucleoside analogs in indolent non-Hodgkin's lymphoma.
    Cabanillas F
    Oncology (Williston Park); 2000 Jun; 14(6 Suppl 2):13-5. PubMed ID: 10887639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer chemotherapy.
    Davey P; Tudhope GR
    Br Med J (Clin Res Ed); 1983 Jul; 287(6385):110-3. PubMed ID: 6407699
    [No Abstract]   [Full Text] [Related]  

  • 8. Topoisomerase I inhibitors and other new cytotoxic drugs.
    Verweij J
    Eur J Cancer; 1995; 31A(5):828-30. PubMed ID: 7640070
    [No Abstract]   [Full Text] [Related]  

  • 9. Fludarabine shows promise for some leukemia patients.
    Oncology (Williston Park); 1989 Mar; 3(3):14. PubMed ID: 2484283
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current status of clinical results of new antitumor drugs].
    Ogawa M
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):179-88. PubMed ID: 3918502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fludarabine phosphate--looking forward.
    Cheson BD
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-2. PubMed ID: 1699277
    [No Abstract]   [Full Text] [Related]  

  • 12. Fludarabine phosphate: an effective therapy for lymphoid malignancies.
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-78. PubMed ID: 1699278
    [No Abstract]   [Full Text] [Related]  

  • 13. Critical review of the determination process by the Japanese reviewing authority in approving the additional efficacy of fludarabine phosphate.
    Narimatsu H; Oiso G; Ono S; Kami M
    J Clin Oncol; 2009 Dec; 27(34):e236-8. PubMed ID: 19884538
    [No Abstract]   [Full Text] [Related]  

  • 14. Fludarabine phosphate in refractory hairy cell leukemia.
    Kraut EH; Chun HG
    Am J Hematol; 1991 May; 37(1):59-60. PubMed ID: 1708945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysis pneumonopathy associated with the use of fludarabine phosphate.
    Crowley JJ; Knight L; Charan N
    West J Med; 1994 Dec; 161(6):597-9. PubMed ID: 7531920
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II trial of fludarabine in patients with epithelial ovarian cancer.
    Kavanagh JJ; Stringer CA; Copeland LJ; Gershenson DM; Saul P
    Cancer Treat Rep; 1986 Mar; 70(3):425-6. PubMed ID: 2420446
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of Sézary syndrome with lymphomatous transformation to large cell lymphoma with fludarabine phosphate.
    Nikko AP; RutherFord CJ; Pandya AG
    Arch Dermatol; 1996 Aug; 132(8):978-9. PubMed ID: 8712858
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of fludarabine phosphate in renal cell carcinoma: a Southwest Oncology Group Study.
    Balducci L; Blumenstein B; Von Hoff DD; Davis M; Hynes HE; Bukowski RM; Crawford ED
    Cancer Treat Rep; 1987 May; 71(5):543-4. PubMed ID: 2436773
    [No Abstract]   [Full Text] [Related]  

  • 19. A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma.
    Grever MR; Benedetti J; Balcerzak SP; Taylor SA; Miller TP; Dakhil SR
    Invest New Drugs; 1994; 12(3):259-61. PubMed ID: 7534752
    [No Abstract]   [Full Text] [Related]  

  • 20. [Successes in late solid tumors. New therapy offer].
    Arnheim K
    MMW Fortschr Med; 2004 Nov; 146(47):71. PubMed ID: 15624667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.